Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Convergence of Peroxisome Proliferator-activated Receptor and Foxo1 Signaling Pathways*
Paul Dowell,
Tamara C. Otto,
Saleh Adi¶, , and
M. Daniel Lane
Biological Chemistry and ¶Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205
Abstract:
The forkhead factor Foxo1 (or FKHR) was identified in a yeasttwo-hybrid screen as a peroxisome proliferator-activated receptor(PPAR) -interacting protein. Foxo1 antagonized PPAR activityand vice versa indicating that these transcription factors functionallyinteract in a reciprocal antagonistic manner. One mechanismby which Foxo1 antagonizes PPAR activity is through disruptionof DNA binding as Foxo1 inhibited the DNA binding activity ofa PPAR/retinoid X receptor heterodimeric complex. The Caenorhabditiselegans nuclear hormone receptor, DAF-12, interacted with theC. elegans forkhead factor, DAF-16, paralleling the interactionbetween PPAR and Foxo1. daf-12 and daf-16 have been implicatedin C. elegans insulin-like signaling pathways, and PPAR andFoxo1 likewise have been linked to mammalian insulin signalingpathways. These results suggest a convergence of PPAR and Foxo1signaling that may play a role in insulin action and the insulinomimeticproperties of PPAR ligands. A more general convergence of nuclearhormone receptor and forkhead factor pathways may be importantfor multiple biological processes and this convergence may beevolutionarily conserved.
Received for publication August 15, 2003.
* This work was supported by Grants DK09894 and DK64934 (to P.D.) and DK38418 (to M. D. L.) from NIDDK, National Institutesof Health and by an Institutional Research Grant from JohnsHopkins University (to S. A.). The costs of publication of thisarticle were defrayed in part by the payment of page charges.This article must therefore be hereby marked "advertisement"in accordance with 18 U.S.C. Section 1734 solely to indicatethis fact.
To whom correspondence should be addressed: Dept. of Biological Chemistry, WBSB 509, 725 N. Wolfe St., Baltimore, MD 21205. Tel.: 410-955-3975; Fax: 410-955-0903; E-mail: dowellp{at}jhmi.edu.
The editors suggest the following Related Resources on Science sites:
A comparative perspective on lipid storage in animals.
K. Birsoy, W. T. Festuccia, and M. Laplante (2013)
J. Cell Sci.
126, 1541-1552
|Abstract »|Full Text »|PDF »
Molecular inflammation and adipose tissue matrix remodeling precede physiological adaptations to pregnancy.
V. Resi, S. Basu, M. Haghiac, L. Presley, J. Minium, B. Kaufman, S. Bernard, P. Catalano, and S. Hauguel-de Mouzon (2012)
Am J Physiol Endocrinol Metab
303, E832-E840
|Abstract »|Full Text »|PDF »
FoxO1 Inhibits Sterol Regulatory Element-binding Protein-1c (SREBP-1c) Gene Expression via Transcription Factors Sp1 and SREBP-1c.
X. Deng, W. Zhang, I. O-Sullivan, J. B. Williams, Q. Dong, E. A. Park, R. Raghow, T. G. Unterman, and M. B. Elam (2012)
J. Biol. Chem.
287, 20132-20143
|Abstract »|Full Text »|PDF »
The Nuclear Orphan Receptor Nur77 Is a Lipotoxicity Sensor Regulating Glucose-Induced Insulin Secretion in Pancreatic {beta}-Cells.
O. Briand, A. Helleboid-Chapman, M. Ploton, N. Hennuyer, R. Carpentier, F. Pattou, B. Vandewalle, E. Moerman, V. Gmyr, J. Kerr-Conte, et al. (2012)
Mol. Endocrinol.
26, 399-413
|Abstract »|Full Text »|PDF »
Survival strategies of a sterol auxotroph.
M. Carvalho, D. Schwudke, J. L. Sampaio, W. Palm, I. Riezman, G. Dey, G. D. Gupta, S. Mayor, H. Riezman, A. Shevchenko, et al. (2010)
Development
137, 3675-3685
|Abstract »|Full Text »|PDF »
From Estrogen-Centric to Aging and Oxidative Stress: A Revised Perspective of the Pathogenesis of Osteoporosis.
Serum- and Glucocorticoid-Inducible Kinase 1 (SGK1) Regulates Adipocyte Differentiation via Forkhead Box O1.
N. Di Pietro, V. Panel, S. Hayes, A. Bagattin, S. Meruvu, A. Pandolfi, L. Hugendubler, G. Fejes-Toth, A. Naray-Fejes-Toth, and E. Mueller (2010)
Mol. Endocrinol.
24, 370-380
|Abstract »|Full Text »|PDF »
Ubiquitin Carboxyl-Terminal Hydrolase L3 Promotes Insulin Signaling and Adipogenesis.
Differential Healing After Sirolimus, Paclitaxel, and Bare Metal Stent Placement in Combination With Peroxisome Proliferator-Activator Receptor {gamma} Agonists: Requirement for mTOR/Akt2 in PPAR{gamma} Activation.
A. V. Finn, M. John, G. Nakazawa, R. Polavarapu, V. Karmali, X. Xu, Q. Cheng, T. Davis, C. Raghunathan, E. Acampado, et al. (2009)
Circ. Res.
105, 1003-1012
|Abstract »|Full Text »|PDF »
Increased Lipid Oxidation Causes Oxidative Stress, Increased Peroxisome Proliferator-activated Receptor-{gamma} Expression, and Diminished Pro-osteogenic Wnt Signaling in the Skeleton.
M. Almeida, E. Ambrogini, L. Han, S. C. Manolagas, and R. L. Jilka (2009)
J. Biol. Chem.
284, 27438-27448
|Abstract »|Full Text »|PDF »
FoxO1 Haploinsufficiency Protects Against High-Fat Diet-Induced Insulin Resistance With Enhanced Peroxisome Proliferator-Activated Receptor {gamma} Activation in Adipose Tissue.
J. J. Kim, P. Li, J. Huntley, J. P. Chang, K. C. Arden, and J. M. Olefsky (2009)
Diabetes
58, 1275-1282
|Abstract »|Full Text »|PDF »
FOXO1 Transrepresses Peroxisome Proliferator-activated Receptor {gamma} Transactivation, Coordinating an Insulin-induced Feed-forward Response in Adipocytes.
W. Fan, T. Imamura, N. Sonoda, D. D. Sears, D. Patsouris, J. J. Kim, and J. M. Olefsky (2009)
J. Biol. Chem.
284, 12188-12197
|Abstract »|Full Text »|PDF »
A PGC-1{alpha}-O-GlcNAc Transferase Complex Regulates FoxO Transcription Factor Activity in Response to Glucose.
M. P. Housley, N. D. Udeshi, J. T. Rodgers, J. Shabanowitz, P. Puigserver, D. F. Hunt, and G. W. Hart (2009)
J. Biol. Chem.
284, 5148-5157
|Abstract »|Full Text »|PDF »
SIRT2 Suppresses Adipocyte Differentiation by Deacetylating FOXO1 and Enhancing FOXO1's Repressive Interaction with PPAR{gamma}.
O-GlcNAc Regulates FoxO Activation in Response to Glucose.
M. P. Housley, J. T. Rodgers, N. D. Udeshi, T. J. Kelly, J. Shabanowitz, D. F. Hunt, P. Puigserver, and G. W. Hart (2008)
J. Biol. Chem.
283, 16283-16292
|Abstract »|Full Text »|PDF »
Regulation of SREBP1c Gene Expression in Skeletal Muscle: Role of Retinoid X Receptor/Liver X Receptor and Forkhead-O1 Transcription Factor.
Y. Kamei, S. Miura, T. Suganami, F. Akaike, S. Kanai, S. Sugita, A. Katsumata, H. Aburatani, T. G. Unterman, O. Ezaki, et al. (2008)
Endocrinology
149, 2293-2305
|Abstract »|Full Text »|PDF »
The emerging role of FOXO transcription factors in pancreatic {beta} cells.
Adaptor Protein SH2-B Linking Receptor-Tyrosine Kinase and Akt Promotes Adipocyte Differentiation by Regulating Peroxisome Proliferator-Activated Receptor {gamma} Messenger Ribonucleic Acid Levels.
D. Yoshiga, N. Sato, T. Torisu, H. Mori, R. Yoshida, S. Nakamura, G. Takaesu, T. Kobayashi, and A. Yoshimura (2007)
Mol. Endocrinol.
21, 1120-1131
|Abstract »|Full Text »|PDF »
PPAR{alpha} mediates the hypolipidemic action of fibrates by antagonizing FoxO1.
S. Qu, D. Su, J. Altomonte, A. Kamagate, J. He, G. Perdomo, T. Tse, Y. Jiang, and H. H. Dong (2007)
Am J Physiol Endocrinol Metab
292, E421-E434
|Abstract »|Full Text »|PDF »
Insulin Regulation of Skeletal Muscle PDK4 mRNA Expression Is Impaired in Acute Insulin-Resistant States..
Y. I. Kim, F. N. Lee, W. S. Choi, S. Lee, and J. H. Youn (2006)
Diabetes
55, 2311-2317
|Abstract »|Full Text »|PDF »
FOXO1 Represses Peroxisome Proliferator-activated Receptor-{gamma}1 and -{gamma}2 Gene Promoters in Primary Adipocytes: A NOVEL PARADIGM TO INCREASE INSULIN SENSITIVITY.
M. Armoni, C. Harel, S. Karni, H. Chen, F. Bar-Yoseph, M. R. Ver, M. J. Quon, and E. Karnieli (2006)
J. Biol. Chem.
281, 19881-19891
|Abstract »|Full Text »|PDF »
Targeting foxo1 in mice using antisense oligonucleotide improves hepatic and peripheral insulin action..
V. T. Samuel, C. S. Choi, T. G. Phillips, A. J. Romanelli, J. G. Geisler, S. Bhanot, R. McKay, B. Monia, J. R. Shutter, R. A. Lindberg, et al. (2006)
Diabetes
55, 2042-2050
|Abstract »|Full Text »|PDF »
FoxO1 Regulates Multiple Metabolic Pathways in the Liver: EFFECTS ON GLUCONEOGENIC, GLYCOLYTIC, AND LIPOGENIC GENE EXPRESSION.
W. Zhang, S. Patil, B. Chauhan, S. Guo, D. R. Powell, J. Le, A. Klotsas, R. Matika, X. Xiao, R. Franks, et al. (2006)
J. Biol. Chem.
281, 10105-10117
|Abstract »|Full Text »|PDF »
Peroxisome Proliferator-Activated Receptor {gamma} Coactivator 1 in Caloric Restriction and Other Models of Longevity.
J. C. Corton and H. M. Brown-Borg (2005)
J Gerontol A Biol Sci Med Sci
60, 1494-1509
|Abstract »|Full Text »|PDF »
Balancing protein similarity and gene co-expression reveals new links between genetic conservation and developmental diversity in invertebrates.
C. Lefebvre, J.-C. Aude, E. Glemet, and C. Neri (2005)
Bioinformatics
21, 1550-1558
|Abstract »|Full Text »|PDF »
Nuclear Hormone Receptors, Metabolism, and Aging: What Goes Around Comes Around.
K. Pardee, J. Reinking, and H. Krause (2004)
Sci. Aging Knowl. Environ.
2004, re8
|Abstract »|Full Text »|PDF »
Regulation of Peroxisome Proliferator-Activated Receptor-{gamma} Activity by Mammalian Target of Rapamycin and Amino Acids in Adipogenesis.
Identification of C. elegans DAF-12-binding sites, response elements, and target genes.
Y. Shostak, M. R. Van Gilst, A. Antebi, and K. R. Yamamoto (2004)
Genes & Dev.
18, 2529-2544
|Abstract »|Full Text »|PDF »
The Forkhead Transcription Factor FoxC2 Inhibits White Adipocyte Differentiation.
K. E. Davis, M. Moldes, and S. R. Farmer (2004)
J. Biol. Chem.
279, 42453-42461
|Abstract »|Full Text »|PDF »
Skeletal Muscle FOXO1 (FKHR) Transgenic Mice Have Less Skeletal Muscle Mass, Down-regulated Type I (Slow Twitch/Red Muscle) Fiber Genes, and Impaired Glycemic Control.
Y. Kamei, S. Miura, M. Suzuki, Y. Kai, J. Mizukami, T. Taniguchi, K. Mochida, T. Hata, J. Matsuda, H. Aburatani, et al. (2004)
J. Biol. Chem.
279, 41114-41123
|Abstract »|Full Text »|PDF »
Nuclear Receptors CAR and PXR Cross Talk with FOXO1 To Regulate Genes That Encode Drug-Metabolizing and Gluconeogenic Enzymes.
S. Kodama, C. Koike, M. Negishi, and Y. Yamamoto (2004)
Mol. Cell. Biol.
24, 7931-7940
|Abstract »|Full Text »|PDF »
A novel nuclear receptor/coregulator complex controls C. elegans lipid metabolism, larval development, and aging.
A. H. Ludewig, C. Kober-Eisermann, C. Weitzel, A. Bethke, K. Neubert, B. Gerisch, H. Hutter, and A. Antebi (2004)
Genes & Dev.
18, 2120-2133
|Abstract »|Full Text »|PDF »
Protein Kinase B/AKT 1 Plays a Pivotal Role in Insulin-like Growth Factor-1 Receptor Signaling Induced 3T3-L1 Adipocyte Differentiation.